News & Updates

Show Multimedia Only
Fluvoxamine wins, metformin disappoints in long COVID fatigue
Fluvoxamine wins, metformin disappoints in long COVID fatigue
10 hours ago byElvira Manzano

The antidepressant fluvoxamine reduces long COVID fatigue, whereas the antidiabetic agent metformin fails to outperform placebo in the randomized REVIVE-TOGETHER trial.

Fluvoxamine wins, metformin disappoints in long COVID fatigue
10 hours ago
COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
17 Jun 2026 byStephen Padilla

Vaccination against COVID-19 provides survival benefits to cancer patients receiving immune checkpoint inhibitors (ICIs), as shown in a recent study.

COVID-19 vaccine improves survival outcomes in cancer patients on ICI therapy
17 Jun 2026